Martyn D. Greenacre
Chairman at CURIS, INC.
Net worth: 14 174 $ as of 2024-03-30
Profile
Martyn D.
Greenacre's current job(s) include Chairman at Curis, Inc., Chairman at Life Mist Technologies, Inc., and Director at Formula Pharmaceuticals, Inc. Mr. Greenacre's former job(s) include President & Chief Executive Officer at Zynaxis, Inc., Chief Executive Officer & Director at Delsys Pharmaceutical Corp., Chairman at Life Mist LLC, Chairman at Beijing Med-Pharm Corp., Director & Chairman-European Operations at Smithkline Beecham Pharmaceuticals (India) Ltd., Chairman at BMP Sunstone Corp., Director at Cephalon, Inc., Director at Creative Biomolecules, Inc., Director at Orchestra Therapeutics, Inc., Director at Acusphere, Inc., Director at NeoStem, Inc., Director at Caladrius Biosciences, Inc., Member-Executive Committee at Applera Corp., and Senior Advisor at Arsenal Capital Management LP.
Mr. Greenacre's education history includes an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CURIS, INC.
0.02% | 2023-07-30 | 1,304 ( 0.02% ) | 14 174 $ | 2024-03-30 |
Martyn D. Greenacre active positions
| Companies | Position | Start |
|---|---|---|
| CURIS, INC. | Chairman | 2017-05-15 |
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Director/Board Member | - |
| Life Mist Technologies, Inc. | Chairman | 2001-12-31 |
Former positions of Martyn D. Greenacre
| Companies | Position | End |
|---|---|---|
| Life Mist LLC | Chairman | 2016-11-30 |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Private Equity Investor | 2011-03-30 |
| Beijing Med-Pharm Corp. | Chairman | 2008-02-18 |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Director/Board Member | 2007-12-31 |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The private company is based in Princeton, NJ. | President | 2001-05-31 |
Training of Martyn D. Greenacre
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| ACUSPHERE, INC. | Health Technology |
| Private companies | 15 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Zynaxis, Inc.
 Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Zynaxis, Inc. develops drug delivery systems. The company is based in Malvern, PA. Zynaxis was acquired by Vaxcel, Inc. on December 06, 1996. | Commercial Services |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
| Life Mist LLC | |
| Beijing Med-Pharm Corp. | Distribution Services |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Finance |
Delsys Pharmaceutical Corp.
Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The private company is based in Princeton, NJ. | Health Technology |
| NeoStem, Inc. /Old/ | Transportation |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
| Life Mist Technologies, Inc. | |
BMP Sunstone Corp.
 BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Health Services |
Formula Pharmaceuticals, Inc.
Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Technology Services |
- Stock Market
- Insiders
- Martyn D. Greenacre
